Astellas Pharma, Inc. (ALPMF)
17.50
+0.75
(+4.48%)
USD |
OTCM |
Oct 26, 16:00
Astellas Pharma Market Cap : 31.38B for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 31.38B |
| October 23, 2026 | 30.03B |
| October 22, 2026 | 30.48B |
| October 21, 2026 | 30.48B |
| October 20, 2026 | 30.12B |
| October 19, 2026 | 29.58B |
| October 16, 2026 | 25.01B |
| October 15, 2026 | 24.12B |
| October 14, 2026 | 23.31B |
| October 13, 2026 | 23.49B |
| October 12, 2026 | 27.43B |
| October 09, 2026 | 27.52B |
| October 08, 2026 | 25.50B |
| October 07, 2026 | 25.55B |
| October 06, 2026 | 27.52B |
| October 05, 2026 | 27.34B |
| October 02, 2026 | 25.77B |
| October 01, 2026 | 26.31B |
| September 30, 2026 | 26.31B |
| September 29, 2026 | 28.33B |
| September 28, 2026 | 29.32B |
| September 25, 2026 | 27.30B |
| September 24, 2026 | 26.98B |
| September 23, 2026 | 28.56B |
| September 22, 2026 | 27.45B |
| Date | Value |
|---|---|
| September 21, 2026 | 27.34B |
| September 18, 2026 | 24.83B |
| September 17, 2026 | 24.83B |
| September 16, 2026 | 24.83B |
| September 15, 2026 | 28.69B |
| September 14, 2026 | 27.97B |
| September 11, 2026 | 28.42B |
| September 10, 2026 | 27.70B |
| September 09, 2026 | 28.06B |
| September 08, 2026 | 28.33B |
| September 04, 2026 | 27.07B |
| September 03, 2026 | 26.55B |
| September 02, 2026 | 26.55B |
| September 01, 2026 | 26.55B |
| August 31, 2026 | 28.51B |
| August 28, 2026 | 27.07B |
| August 27, 2026 | 29.58B |
| August 26, 2026 | 25.10B |
| August 25, 2026 | 28.42B |
| August 24, 2026 | 28.42B |
| August 21, 2026 | 29.14B |
| August 20, 2026 | 29.50B |
| August 19, 2026 | 27.25B |
| August 18, 2026 | 27.25B |
| August 17, 2026 | 28.33B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 64.57B |
| Daiichi Sankyo Co., Ltd. | 32.57B |
| Eisai Co., Ltd. | 9.152B |
| Chugai Pharmaceutical Co., Ltd. | 71.70B |
| Santen Pharmaceutical Co., Ltd. | 3.658B |
Market Cap Related Metrics
| PE Ratio | 13.35 |
| PS Ratio | 2.138 |
| PEG Ratio | 0.0419 |
| Price to Book Value | 2.625 |
| Price to Free Cash Flow | 10.56 |
| Price | 17.50 |
| Earnings Yield | 7.49% |
| PEGY Ratio | 0.0415 |
| Operating PE Ratio | 9.825 |
| Normalized PE Ratio | 13.35 |